RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Utah Medical Products Stock

Utah Medical Products ROE 2025

Utah Medical Products ROE

0.12

Ticker

UTMD

ISIN

US9174881089

WKN

882656

In 2025, Utah Medical Products's return on equity (ROE) was 0.12, a -8.87% increase from the 0.13 ROE in the previous year.

Utah Medical Products Aktienanalyse

What does Utah Medical Products do?

Utah Medical Products Inc. (UMPI) is a US-based company specializing in medical devices and products. It was founded in 1978 and has since developed an impressive range of innovative products. UMPI began with the idea of creating a better device for monitoring pregnant women and their unborn children. The first product, called "FetalGard," was a non-invasive device for quickly and accurately measuring fetal heart rates. This technology was revolutionary at the time and helped doctors and nurses make accurate diagnoses and ensure optimal obstetric care. UMPI has expanded its product range and now covers a variety of medical specialties, including gynecology/restorative, neonatology/perinatology, and blood pressure measurement. In the gynecology/restorative field, UMPI offers a wide range of products to support women's medical needs, including devices for the diagnosis and treatment of cervical cancer, obstetric instruments, and products for post-gynecological surgery recovery. The neonatology/perinatology field includes products for preterm birth prevention and support of premature infants. UMPI, for example, has developed a variety of devices for monitoring and supporting newborns, such as the "Flexxus Hydrosense," which can contribute to measuring fluid levels in newborns. In the field of blood pressure measurement, UMPI has developed a range of devices to assist doctors and medical personnel in conducting blood pressure measurements. The company is known for its highly accurate blood pressure monitors, such as the "Deltran Plus," which can be used for blood pressure measurements in adults, children, and infants. UMPI's business model focuses on the development of high-quality medical devices. The company aims to create value through these devices and help doctors and medical personnel achieve better medical outcomes. The company is proud that its products help improve patients' lives and enhance the performance of healthcare professionals. UMPI has a network of distributors and partners worldwide who contribute to making high-quality products available in the market. The company places great importance on compliance with standards and regulations and works closely with the relevant regulatory authorities. Overall, Utah Medical Products Inc. has an excellent reputation in the medical industry and is considered a reliable provider of high-quality medical devices and products. Through its innovative technology and commitment to improving medical outcomes, the company has made a significant contribution to the medical industry and will continue to play an important role in the future. Utah Medical Products ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Utah Medical Products's Return on Equity (ROE)

Utah Medical Products's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Utah Medical Products's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Utah Medical Products's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Utah Medical Products’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Utah Medical Products stock

What is the ROE (Return on Equity) of Utah Medical Products this year?

The ROE of Utah Medical Products this year is 0.12 undefined.

How has the Return on Equity (ROE) of Utah Medical Products developed compared to the previous year?

The ROE of Utah Medical Products has increased by -8.87% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Utah Medical Products?

A high ROE indicates that Utah Medical Products generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Utah Medical Products?

A low ROE can indicate that Utah Medical Products is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Utah Medical Products affect the company?

A change in ROE (Return on Equity) of Utah Medical Products can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Utah Medical Products?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Utah Medical Products?

Some factors that can influence Utah Medical Products's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Utah Medical Products pay?

Over the past 12 months, Utah Medical Products paid a dividend of 1.2 USD . This corresponds to a dividend yield of about 2.17 %. For the coming 12 months, Utah Medical Products is expected to pay a dividend of 1.2 USD.

What is the dividend yield of Utah Medical Products?

The current dividend yield of Utah Medical Products is 2.17 %.

When does Utah Medical Products pay dividends?

Utah Medical Products pays a quarterly dividend. This is distributed in the months of October, January, April, July.

How secure is the dividend of Utah Medical Products?

Utah Medical Products paid dividends every year for the past 20 years.

What is the dividend of Utah Medical Products?

For the upcoming 12 months, dividends amounting to 1.2 USD are expected. This corresponds to a dividend yield of 2.17 %.

In which sector is Utah Medical Products located?

Utah Medical Products is assigned to the 'Health' sector.

Wann musste ich die Aktien von Utah Medical Products kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Utah Medical Products from 7/3/2025 amounting to 0.305 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2025.

When did Utah Medical Products pay the last dividend?

The last dividend was paid out on 7/3/2025.

What was the dividend of Utah Medical Products in the year 2024?

In the year 2024, Utah Medical Products distributed 1.185 USD as dividends.

In which currency does Utah Medical Products pay out the dividend?

The dividends of Utah Medical Products are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Utah Medical Products

Our stock analysis for Utah Medical Products Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Utah Medical Products Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.